Miho Mizutani

Statistics

Publications

Citations

736

H-Index

Active since

1994

Affiliations

Institute of Medicinal Molecular Design(Current)

The University of Tokyo

NTT Medical Center

Tokyo Medical and Dental University

Takeda (United States)

Miho Mizutani is an author at Institute of Medicinal Molecular Design specializing in medicinal chemistry, protein-ligand docking, and drug discovery.

Publications per year

1994–2021

Publications

Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer

Steven Langston, Stephen Grossman, Dylan B. England et al. · Journal of Medicinal Chemistry · 2021 · 208 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +11

Rational Automatic Search Method for Stable Docking Models of Protein and Ligand

Miho Mizutani, Nobuo Tomioka, Akiko Itai · Journal of Molecular Biology · 1994 · 129 citations

Pharmacy, Medicinal Chemistry, Computational Chemistry +11

Efficient Method for High-Throughput Virtual Screening Based on Flexible Docking: Discovery of Novel Acetylcholinesterase Inhibitors

Miho Mizutani, Akiko Itai · Journal of Medicinal Chemistry · 2004 · 65 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Effective handling of induced‐fit motion in flexible docking

Miho Mizutani, Yoshihiro Takamatsu, Tazuko Ichinose et al. · Proteins Structure Function and Bioinformatics · 2006 · 63 citations

Life Sciences, Medicinal Chemistry, Biomolecular Modeling +9

Acute cerebellitis caused byCoxiella burnetii

Yukio Sawaishi, Ikuo Takahashi, Yasuhiro Hirayama et al. · Annals of Neurology · 1999 · 60 citations

Medicine, Infectious Diseases, Neurology +8

1–5 of 12